Last reviewed · How we verify
18F-S16
At a glance
| Generic name | 18F-S16 |
|---|---|
| Sponsor | Oriental Neurosurgery Evidence-Based-Study Team |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Tau PET/CT in Various Tau-Related Disease Patients
- 18F-S16 PET/CT in Healthy Volunteers and Patients With Neurodegenerative Dementia (EARLY_PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- 18F-S16 CI brief — competitive landscape report
- 18F-S16 updates RSS · CI watch RSS
- Oriental Neurosurgery Evidence-Based-Study Team portfolio CI